Consistent with the results of liver developmental studies, one member of the FoxA family, FOXA1, works as a pioneer factor in the AR and estrogen receptor (ER) pathways in prostate cancer and breast cancer cells [52,53,54]. Here, FOXA1 is linked to breast carcinoma.